Influence of participant and reviewer characteristics in application scores for a hematology research training program.
Journal
Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425
Informations de publication
Date de publication:
08 08 2023
08 08 2023
Historique:
accepted:
10
03
2023
received:
20
01
2023
medline:
31
7
2023
pubmed:
21
3
2023
entrez:
20
3
2023
Statut:
ppublish
Résumé
The American Society of Hematology Clinical Research Training Institute (CRTI) is a clinical research training program with a competitive application process. The objectives were to compare application scores based on applicant and reviewer sex and underrepresented minority (URM) status. We included applications to CRTI from 2003 to 2019. The application scores were transformed into a scale from 0 to 100 (100 was the strongest). The factors considered were applicant and reviewer sex and URM status. We evaluated whether there was an interaction between the characteristics and time related to application scores. In total, 713 applicants and 2106 reviews were included. There was no significant difference in scores according to applicant sex. URM applicants had significantly worse scores than non-URM applicants (mean [standard error] 67.9 [1.56] vs 71.4 [0.63]; P = .0355). There were significant interactions between reviewer sex and time (P = .0030) and reviewer URM status and time (P = .0424); thus, results were stratified by time. For the 2 earlier time periods, male reviewers gave significantly worse scores than did female reviewers; this difference did not persist for the most recent time period. The URM reviewers did not give significantly different scores across time periods. URM applicants received significantly lower scores than non-URM applicants. The impact of reviewer sex and URM status changed over time. Although male reviewers gave lower scores in the early periods, this effect did not persist in the late period. Efforts are required to mitigate the impact of applicant URM status on application scores.
Identifiants
pubmed: 36939221
pii: 494974
doi: 10.1182/bloodadvances.2023009792
pmc: PMC10388723
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
4064-4071Subventions
Organisme : NHLBI NIH HHS
ID : K24 HL148305
Pays : United States
Informations de copyright
© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Références
Acad Med. 2015 Aug;90(8):1061-6
pubmed: 26222198
Curr Probl Pediatr Adolesc Health Care. 2019 Feb;49(2):34-44
pubmed: 30738896
Immunol Cell Biol. 2022 Oct;100(9):674-678
pubmed: 35748687
JCO Oncol Pract. 2022 Dec;18(12):791-799
pubmed: 36215686
Blood Adv. 2020 Feb 25;4(4):755-761
pubmed: 32097459
Clin Gastroenterol Hepatol. 2021 Mar;19(3):419-420
pubmed: 33279782
Blood. 2004 Jun 15;103(12):4383-8
pubmed: 14764525
Blood. 2016 Dec 22;128(25):2881-2885
pubmed: 27784672
Adv Dent Res. 2019 Dec;30(3):69-77
pubmed: 31746653
J Cancer Educ. 2015 Dec;30(4):754-8
pubmed: 25387653
Ecol Evol. 2019 Mar 04;9(6):3599-3619
pubmed: 30962913
Science. 2011 Aug 19;333(6045):1015-9
pubmed: 21852498